65,437 trials
Spondylitis, Ankylosing
Primary: Percentage of Participants Who Experienced Flare Within 40 Weeks Following Withdrawal of 24 Weeks of Etanercept Treatment — 74.8 percentage of participants
Breast Cancer · Breast Neoplasm
Primary: Number of Participants With Clinical Benefit (CB) — 13 Participants
Breast Neoplasms
Primary: Number of Participants Who Had Breast Cancer Recurrence After Breast Cancer Surgery — 111; 102 participants — p=0.84
Primary Immunodeficiency
Primary: Rate of Serious Bacterial Infection (SBI) Per Participant Per Year — 0; 0.023; 0.017 Rate of events per participant per year
Healthy Volunteers
Primary: Cmax: Maximum Observed Serum Concentration — 83000; 65200; 74400 (ng/mL)/(mg/mL)
Cushings Disease
Primary: Percentage of Primary Efficacy Responder at Week 34 by Randomized Treatment and Strata — 86.1; 29.4 Percentage of participants — p=<.001
Parkinson's Disease
Primary: Number of Participants With Serious Adverse Events — 0; 0; 0 Participants
Renal Dialysis
Primary: Patient Engagement With patientMpower App to Record Body Weight — 24 days
Healthy
Primary: Center of Pressure — -42.76; -34.98; -118.34; -122.16 mm
Type 2 Diabetes · Mild Cognitive Impairment
Primary: Percent of Participants With Improvement in Hemoglobin A1c by 0.5%" — 25; 22 Participants — p=0.31
Delirium · Postoperative Cognitive Dysfunction
Primary: Feasibility of Providing a Neurocognitive Training Program to Elderly Cardiac Surgical Patients - Enrollment — 45 Participants
Chronic Obstructive Pulmonary Disease
Primary: The Magnitude of Change in Isokinetic Power (Performance Fatigue, PF) Associated With Stiolto Respimat Compared With Placebo Respimat at Isotime During Constant Work…
Locally Advanced Bone Sarcoma · Locally Advanced Dedifferentiated Liposarcoma · Locally Advanced Gastrointestinal Stromal Tumor
Primary: Number of Participants Who Achieved a Confirmed Response — 2; 6; 1; 2 Participants
Opioid-Related Disorders
Primary: Number of Participants With New Arrests — 2; 2 Participants
Fibromyalgia
Primary: Visual Analog Scale-Pain — 5.30; 6.80 units on a scale